| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_371d5e1401b1b6d069500cdd13241b85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2afec86507fc41d4fd24a6693763f876
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_147c327a0cb6282aa46430535f4ba112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcd6fafadaa360d81ca23ce6e64922f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d657e9fd640624251fb1b7458910ef98 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate |
2007-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bdc5c582446111f3ed1d7884a360fb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0b57862498dea9c2cae8069249995c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c6590f5fb83cc0a8bcc249bb8f9df17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d58b74b280cdb5adebf8d8b1d7271ddb |
| publicationDate |
2007-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007129837-A1 |
| titleOfInvention |
Composition for transdermal absorption and formulation comprising a polymeric matrix formed therefrom |
| abstract |
The inventive composition for transdermal absorption characterized by comprising a nonsteroidal anti-inflammatory drug as an active ingredient together with an alkali metal-containing alcohol derivative as a solubilizing agent for the active ingredient comprises a high concentration of the active ingredient while using only a small amount of the solvent, and a transdermal absorption formulation comprising a polymeric matrix formed from the composition is capable of maximizing the skin absorption of the active ingredient with minimal skin irritation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012022837-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014028049-A1 |
| priorityDate |
2006-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |